Amyloid Precursor Protein Modulates ERK‐1 and ‐2 Signaling

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1196/annals.1378.048PMID 17384289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Apoptotic cell death influences the signaling activity of the amyloid precursor protein through ShcA and Grb2 adaptor proteins in neuroblastoma SH‐SY5Y cells

  2004cited by this paper
• Caveolar and Lipid Raft Localization of the Growth Hormone Receptor and Its Signaling Elements

  2004cited by this paper
• Alzheimer disease therapy: can the amyloid cascade be halted?

  2003cited by this paper
• Grb2 regulates internalization of EGF receptors through clathrin-coated pits.

  2003cited by this paper
• p21-activated Kinase 1 (PAK1) Interacts with the Grb2 Adapter Protein to Couple to Growth Factor Signaling*

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Phosphatidylinositol 4,5-Biphosphate (PIP2)-induced Vesicle Movement Depends on N-WASP and Involves Nck, WIP, and Grb2* 210

  2002cited by this paper
• The γ-secretase-generated intracellular domain of β-amyloid precursor protein binds Numb and inhibits Notch signaling

  2002cited by this paper
• Fear memory formation involves p190 RhoGAP and ROCK proteins through a GRB2-mediated complex.

  2002cited by this paper
• Evidence for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation and processing of beta-APP.

  2002cited by this paper
• Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis

  2002cited by this paper
• Signal Transduction through Tyrosine-phosphorylated C-terminal Fragments of Amyloid Precursor Protein via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease Brain*

  2002cited by this paper
• The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling.

  2002cited by this paper
• Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

  2002cited by this paper
• Jun NH2-terminal Kinase (JNK) Interacting Protein 1 (JIP1) Binds the Cytoplasmic Domain of the Alzheimer's β-Amyloid Precursor Protein (APP)*

  2002cited by this paper
• Endocytosis of Epidermal Growth Factor Receptor Regulated by Grb2-mediated Recruitment of the Rab5 GTPase-activating Protein RN-tre*

  2002cited by this paper
• Tyrosine Phosphorylation of the β-Amyloid Precursor Protein Cytoplasmic Tail Promotes Interaction with Shc*

  2002cited by this paper
• Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts

  2001cited by this paper
• Identification of Amino-Terminally and Phosphotyrosine-Modified Carboxy-Terminal Fragments of the Amyloid Precursor Protein in Alzheimer's Disease and Down's Syndrome Brain

  2001cited by this paper
• MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit.

  2001cited by this paper
• Grb2 dominantly associates with dynamin II in human hepatocellular carcinoma HepG2 cells

  2001cited by this paper
• The β-Amyloid Precursor Protein APP Is Tyrosine-phosphorylated in Cells Expressing a Constitutively Active Form of the Abl Protoncogene*

  2001cited by this paper
• Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.

  2001cited by this paper
• Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug‐induced apoptosis in neuroblastoma cells

  2001cited by this paper
• Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer

  2001cited by this paper
• beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations.

  2001cited by this paper
• The Disabled 1 Phosphotyrosine-Binding Domain Binds to the Internalization Signals of Transmembrane Glycoproteins and to Phospholipids

  1999cited by this paper
• Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain.

  1998cited by this paper
• Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation.

  1998cited by this paper
• Interaction of the Phosphotyrosine Interaction/Phosphotyrosine Binding-related Domains of Fe65 with Wild-type and Mutant Alzheimer's β-Amyloid Precursor Proteins*

  1997cited by this paper
• The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein

  1996cited by this paper
• Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.

  1996cited by this paper
• Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein

  1996cited by this paper
• Interaction of Grb2 via its Src homology 3 domains with synaptic proteins including synapsin I.

  1994cited by this paper
• Direct interaction between Shc and the platelet-derived growth factor beta-receptor.

  1994cited by this paper
• The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

  1993cited by this paper

• β-amyloid and β-amyloid precursor protein synthesis and processing: effects of exercise and exercise-related injury.

  2026cites this paper
• MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson's disease.

  2025cites this paper
• Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders

  2025cites this paper
• Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases

  2025cites this paper
• Dysfunctional proteins in neuropsychiatric disorders: from neurodegeneration to Autism Spectrum Disorders.

  2020cites this paper
• Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells

  2020cites this paper
• Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder

  2019cites this paper
• Amyloid precursor protein is overexpressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors

  2018cites this paper
• The impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer's disease.

  2018cites this paper
• Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety

  2017cites this paper
• Synergic interaction between amyloid precursor protein and neural cell adhesion molecule promotes neurite outgrowth

  2016cites this paper
• APP Receptor? To Be or Not To Be.

  2016cites this paper
• Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue

  2016cites this paper
• Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway

  2014cites this paper
• Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway

  2013cites this paper
• NGF and APP Interplay: Focus on YENPTY Motif of Amyloid Precursor Protein and Y682 Residue

  2013cites this paper
• Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling

  2012cites this paper
• Mutant Presenilin 2 Increases &bgr;-Secretase Activity Through Reactive Oxygen Species–Dependent Activation of Extracellular Signal–Regulated Kinase

  2012cites this paper
• Activation of a-secretases : a novel therapeutic strategy for the treatment of traumatic brain injury ; L'activation des α-sécrétases : une nouvelle stratégie thérapeutique pour le traitement du traumatisme crânien

  2012cites this paper
• Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging

  2011cites this paper
• Proteome alterations of cortex and hippocampus tissues in mice subjected to vitamin A depletion.

  2011cites this paper
• The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer’s disease

  2010cites this paper
• The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer’s disease

  2010cites this paper
• Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.

  2009cites this paper
• Phosphorylation of beta‐amyloid precursor protein (APP) cytoplasmic tail facilitates amyloidogenic processing during apoptosis

  2008cites this paper